Aims Vascular integrity is disturbed in shock contributing to clinical appearance and serious
outcomes. While angiopoietin (Ang)-1 protects from vascular inflammation and leakage, Ang …

BACKGROUND: Patients presenting with cardiogenic shock (CS) are at risk of developing
mixed shock (MS), characterized by distributive-inflammatory phenotype. However, no …

Heart failure (HF) has a global prevalence of 1–2%, and the incidence around the world is
growing. The prevalence increases with age, from around 1% for those aged< 55 years to> …

Cardiogenic shock is a state of reduced cardiac output leading to hypotension, pulmonary
congestion, and hypoperfusion of tissues and vital organs. Despite the advances in …

Mechanical reperfusion with primary angioplasty, as the treatment of choice in acute
myocardial infarction (MI), is associated not only with a high percentage of full epicardial and …

Biomarkers are useful for diagnosis, disease monitoring and risk stratification in
cardiovascular disease. Cardiogenic shock (CS) is a medical emergency caused by a …

Emerging clinical evidence has suggested that short-term mechanical augmentation of
cardiac output (CO) may not consistently improve mortality in patients with cardiogenic …

Background Inflammatory responses play an important role in the pathophysiology of
cardiogenic shock (CS). The aim of this study was to investigate the kinetics of procalcitonin …

Cardiogenic shock (CS) is a dramatic and highly lethal condition that has long presented a
challenge to those who care for patients in the cardiac intensive care unit (CICU). CS …

Despite venovenous or venoarterial extracorporeal membrane oxygenation (ECMO) being
increasingly used in patients with severe acute respiratory disease syndrome, severe …